The study, led by researchers from Shanghai Jiao Tong University and affiliated institutions, evaluates how functional surface coatings can improve the biological connection between implants and surrounding tissues. Unlike osseointegration, which focuses on bone bonding, soft tissue integration involves the complex interplay of mucosa, skin, and muscle with implant surfaces. The authors argue that a one-size-fits-all approach to coating design is insufficient because each tissue type presents distinct biological challenges and mechanical demands.
The review examines three specific interfaces: oral mucosa around dental abutments, craniofacial muscle and enthesis around temporomandibular joint (TMJ) prostheses, and skin around percutaneous implants. Each of these interfaces requires different biological responses to ensure stability and function. For instance, oral mucosa must form a rapid seal against continuous plaque exposure, while percutaneous skin must prevent epithelial downgrowth across a permanent breach. The authors emphasize that direct integrative effects must be distinguished from infection control and immunomodulation, as these mechanisms serve different purposes in the healing process.
In the oral cavity, the primary challenge is the formation of a stable biological seal around dental implants. The review notes that deficient keratinized mucosa width, particularly less than 2 mm, is strongly associated with plaque biofilm formation, inflammation, and mucosal recession. These conditions can lead to attachment loss and peri-implant disease. Coatings for dental abutments are therefore evaluated based on their ability to support epithelial attachment, fibroblast organization, and collagen orientation. The authors highlight that even under favorable conditions, the peri-implant soft tissue closure is less mechanically resistant than natural periodontal attachment, necessitating careful design of surface modifications.
Several coating strategies have been explored for dental implants, including extracellular matrix (ECM) mimetic bioactive coatings and ionic modifications. ECM components such as laminin 332 and fibronectin have been shown to promote cell adhesion, migration, and differentiation in human gingival fibroblasts. For example, a composite coating containing laminin 332 displayed a 28-day staged release and promoted cell adhesion via the PI3K-Akt pathway. However, the authors caution that cellular responses alone do not prove the formation of a durable mucosal seal in vivo. Translational challenges, including protein sourcing, sterilization, and storage stability, remain significant barriers to clinical application.
TMJ prostheses present a unique challenge because they function in a moving joint, requiring muscle attachment to restore mobility and function. During total TMJ replacement, the lateral pterygoid muscle is often detached, which can impair lateral and protrusive mandibular movements. The review highlights that the reconstruction problem is closer to the regeneration of an enthesis-like junction than simple myoblast ingrowth. Therefore, muscle-facing coatings must be assessed for organized collagenous attachment, vascularization, and interfacial load transfer under repetitive motion. Current evidence for coating-mediated TMJ muscle attachment remains at the proof-of-concept stage in non-TMJ models.
Recent studies have explored the use of bioactive coatings to enhance muscle integration with TMJ prostheses. One study by Wei et al. prepared a porous titanium scaffold bearing a bilayer carbon nanotubes/mesoporous silica nanoparticles coating loaded with mechano-growth factor. This coating enhanced myoblast attachment and myogenic maturation, with muscle growing into the porous scaffold rather than forming fibrotic tissue. Another study by Su et al. combined microgrooves with covalent immobilization of hyaluronic acid and a pro-angiogenic tripeptide on PEEK, a candidate material for TMJ prostheses. These surfaces strengthened interfacial adhesion and supported myoblast differentiation. However, the authors note that these studies were not performed in a TMJ or under masticatory loading, limiting their direct clinical applicability.
Percutaneous implants, such as bone-anchored hearing aids, require a stable biological skin seal to prevent bacterial invasion. The skin epithelium serves as the primary barrier against microbial pathogens, but the percutaneous region often lacks firm soft tissue attachment. This can lead to epithelial downgrowth and the formation of moist pockets that are susceptible to bacterial and fungal colonization. Coatings for percutaneous implants must support epidermal and dermal anchorage while limiting downgrowth. The review points out that unlike osseointegration, skin integration around metallic prostheses remains a mechanically inferior adaptation, making surface modification crucial for long-term success.
Inorganic and bioactive coatings have been investigated for percutaneous implants, with mixed results. Inorganic coatings such as gold, alumina, and zirconia have been used to reduce peri-implant inflammation and enhance cell adhesion. For example, a study by Steyl et al. found that fluorapatite-coated titanium devices in a sheep model improved healing and restricted epithelial downgrowth after 12 weeks. However, this model differs anatomically from craniofacial sites and requires longer-term confirmation. Bioactive coatings, such as those derived from ECM components, have also shown promise in promoting epithelial adhesion. A study by Saad et al. demonstrated that collagen-functionalized PEEK implants increased epithelial cell viability and adhesion, but these cellular responses do not establish a durable skin seal.
The review also highlights the importance of distinguishing between different types of coating functions. Direct integrative coatings aim to promote tissue attachment and matrix organization, while infection-control coatings are designed to reduce plaque contamination. Immunomodulatory coatings can modulate the healing environment, but neither antibacterial nor anti-inflammatory activity alone demonstrates the formation of a durable tissue seal. The authors argue that interface-specific coatings should be designed around a primary tissue-level endpoint, with antimicrobial and immunomodulatory functions treated as supportive and dose-limited. This approach ensures that coatings are tailored to the specific biological and mechanical demands of each interface.
Translational challenges remain significant for the clinical adoption of these coatings. The review identifies several key barriers, including the preservation of biological activity during manufacturing and storage, mechanical robustness, and the need for standardized evaluation systems. Protein-based coatings are particularly vulnerable to proteolytic degradation, and their long-term stability is a concern. Additionally, the evaluation of coating performance under simultaneous mechanical and microbial challenge is lacking in current studies. The authors recommend that future research should introduce these factors to the evaluation of the tissue-implant interface, assessing seal permeability, bacterial penetration, and epithelial downgrowth under realistic conditions.
The authors propose a staged evaluation framework to make evidence more comparable and convincing. Cell studies should establish mechanism and cytocompatible dose ranges, while small animal studies should quantify attachment, downgrowth, and inflammatory response. Large-animal models should add surgical insertion, motion, and microbial challenge, and clinical studies should evaluate infection, survival rates, and functional outcomes. This framework provides realistic expectations and prevents surrogate cellular-level results from being treated as clinical outcomes. The review concludes that the field should move from general biocompatibility toward interface-specific design, with a focus on durable coating chemistries and long-term clinical validation.
In conclusion, the narrative review provides a comprehensive overview of the current state of functional coatings for craniofacial implants. It highlights the distinct biological requirements of oral mucosa, percutaneous skin, and craniofacial muscle, and the need for interface-specific coating strategies. While significant progress has been made in understanding cellular responses and preclinical outcomes, the evidence for durable tissue integration remains limited. The authors emphasize the importance of rigorous evaluation under realistic conditions and the need for further research to overcome translational challenges.
The review distinguishes between direct integrative effects and supportive functions like infection control, noting that favorable cell behavior or added antibacterial activity does not necessarily produce a durable tissue seal. This conceptual separation is critical because many current studies rely on cellular adhesion, spreading, or gene expression as primary endpoints. The authors argue that these mechanistic signals must be validated against tissue-level outcomes, such as epithelial downgrowth, collagen orientation, and seal permeability, to be considered evidence of true integration. Without this distinction, the field risks conflating temporary biological responses with the stable, functional attachments required for long-term implant success in clinical settings.
Negative findings from animal models further underscore the complexity of translating coating chemistry into tissue outcomes. For instance, a porous titanium flange carrying hydroxyapatite, fibronectin, and antibacterial silver did not reduce epithelial downgrowth in a sheep model, despite the presence of components individually associated with favorable cellular responses. Similarly, collagen entrapped in anodized titanium dioxide produced a healing response similar to uncoated implants in dog models, suggesting that molecular presence alone may not ensure retained bioactivity or appropriate tissue anchorage. These results highlight that the physical presentation, degradation kinetics, and immobilization stability of coating components are as important as their chemical identity in determining final tissue integration.
For percutaneous implants, the challenge of maintaining a seal across a permanent epithelial breach remains particularly difficult. While fluorapatite-coated titanium devices showed improved healing and restricted downgrowth in a 12-week sheep study, this anatomical model differs significantly from craniofacial sites in terms of loading, soft-tissue thickness, and motion. The authors caution that findings from limb-amputation prostheses or other transcutaneous devices should guide hypotheses rather than be assumed to transfer directly to craniofacial applications. Long-term stability and the ability to resist microbial invasion under realistic mechanical stress remain unproven for most current coating strategies, necessitating further investigation in anatomically relevant models.
Future research must address the lack of standardized evaluation protocols that combine mechanical and microbial challenges. Current studies often fail to assess seal integrity under conditions that mimic the simultaneous forces of chewing, speech, or external contamination. A staged evaluation framework is proposed to bridge this gap, moving from cellular mechanism studies to large-animal models that include surgical insertion, motion, and microbial challenge. This approach aims to prevent surrogate cellular-level results from being misinterpreted as clinical outcomes, ensuring that coating development is grounded in realistic biological and mechanical demands.
Subject of Research: Interface-specific functional coatings for soft-tissue integration of craniofacial implants: oral mucosa, percutaneous skin, and muscle
Article Title: Interface-specific functional coatings for soft-tissue integration of craniofacial implants: oral mucosa, percutaneous skin, and muscle
Article References: Long, Q., Wu, W., Xu, Z., Li, Z., Hu, Y., Zhao, C., & Wu, H. (2026). Interface-specific functional coatings for soft-tissue integration of craniofacial implants: oral mucosa, percutaneous skin, and muscle. Frontiers in Bioengineering and Biotechnology, 14, Article 1952904. https://doi.org/10.3389/fbioe.2026.1952904
Image Credits: AI Generated
DOI: 10.3389/fbioe.2026.1952904
Keywords: Interface-specific, functional, coatings, soft-tissue, integration, craniofacial, implants, oral, mucosa, percutaneous, skin, muscle
News Source: Gregory Coleman. (November 10, 2026). Review: Coatings for Craniofacial Implants Need Interface-Specific Design. Scienmag.
